BIOR - Biora IND for BT-600 delayed due to FDA request for more info
2023-10-23 18:48:57 ET
More on Biora Therapeutics
- Biora Therapeutics, Inc. (BIOR) Q2 2023 Earnings Call Transcript
- Biora Therapeutics reduces debt by $50M, largest shareholder increases equity exposure
- Biora gains after update on drug delivery device
- Seeking Alpha’s Quant Rating on Biora Therapeutics
- Historical earnings data for Biora Therapeutics
For further details see:
Biora IND for BT-600 delayed due to FDA request for more info